Comorbidity burden in patients undergoing left atrial appendage closure.

atrial arrhythmia ablation procedures electrophysiology epidemiology stroke

Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
12 Jul 2021
Historique:
received: 07 07 2020
revised: 11 10 2020
accepted: 16 10 2020
medline: 25 11 2020
pubmed: 25 11 2020
entrez: 24 11 2020
Statut: epublish

Résumé

To estimate the risk of in-hospital complications after left atrial appendage closure (LAAC) in relationship with comorbidity burden. Cohort-based observational study using the US National Inpatient Sample database, 1 October 2015 to 31 December 2017. The main outcome of interest was the occurrence of in-hospital major adverse events (MAE) defined as the composite of bleeding complications, acute kidney injury, vascular complications, cardiac complications and postprocedural stroke. Comorbidity burden and thromboembolic risk were assessed by the Charlson Comorbidity Index (CCI), Elixhauser Comorbidity Score (ECS) and CHA A total of 3294 hospitalisations were identified, among these, the mean age was 75.7±8.2 years, 60% were male and 86% whites. The mean CHA In this large cohort of LAAC patients, the majority of them had significant comorbidity burden. In-hospital MAE occurred in 4.6% and female patients, non-whites and those with higher burden of comorbidities were at higher risk of in-hospital MAE after LAAC.

Identifiants

pubmed: 33229360
pii: heartjnl-2020-317741
doi: 10.1136/heartjnl-2020-317741
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1246-1253

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DH is on the Advisory Board for Boston Scientific, unpaid.

Auteurs

Shubrandu Sanjoy (S)

Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Yun-Hee Choi (YH)

Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

David Holmes (D)

Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Howard Herrman (H)

Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Juan Terre (J)

Division of Cardiology, Albert Einstein College of Medicine, New York, New York, USA.

Chadi Alraies (C)

Division of Cardiology, Wayne State University, Detroit, Michigan, USA.

Tomo Ando (T)

Division of Cardiology, Kawasaki Saiwai Hospital, Kawasaki, Japan.

Nikolaos Tzemos (N)

Division of Cardiology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University; London Health Sciences Centre, London, Ontario, Canada.

Mamas Mamas (M)

Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute of Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK.

Rodrigo Bagur (R)

Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada rodrigobagur@yahoo.com.
Division of Cardiology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University; London Health Sciences Centre, London, Ontario, Canada.
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute of Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK.

Classifications MeSH